Scarica l'app Stockscreener
10.15
13.41%
1.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$8.95
Aprire:
$9.03
Volume 24 ore:
1.12M
Relative Volume:
1.34
Capitalizzazione di mercato:
$417.33M
Reddito:
$128.29M
Utile/perdita netta:
$-30.69M
Rapporto P/E:
-12.38
EPS:
-0.82
Flusso di cassa netto:
$-27.17M
1 W Prestazione:
+4.32%
1M Prestazione:
+16.53%
6M Prestazione:
-36.60%
1 anno Prestazione:
-77.47%
Intervallo 1D:
$9.03
$10.40
Intervallo di 1 settimana:
$8.80
$10.40
Portata 52W:
$6.32
$47.89
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Confronta RXST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
10.15 | 367.99M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Downgrade | Jefferies | Buy → Hold |
| 2025-07-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Iniziato | Piper Sandler | Neutral |
| 2025-04-09 | Downgrade | UBS | Buy → Neutral |
| 2025-04-04 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
Will RxSight Inc. stock attract ESG investors2025 Performance Recap & Advanced Swing Trade Entry Plans - newser.com
What risks investors should watch in RxSight Inc. stockTrade Volume Summary & Detailed Earnings Play Strategies - newser.com
RxSight, Inc. to Present at the Piper Sandler Healthcare Conference - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Is Investigating RxSight, Inc. (RXST) And Encourages Shareholders to Connect - ACCESS Newswire
Is RxSight Inc. stock a defensive play in 2025Portfolio Update Report & Long-Term Safe Investment Plans - newser.com
Combining price and volume data for RxSight Inc.Rate Hike & Risk Managed Investment Entry Signals - newser.com
Can RxSight Inc. stock continue upward trend2025 Top Gainers & High Accuracy Buy Signal Tips - newser.com
Can RxSight Inc. stock deliver surprise earnings beatQuarterly Trade Summary & Verified Entry Point Signals - newser.com
Will a bounce in RxSight Inc. offer an exitEarnings Overview Report & Low Risk High Win Rate Picks - newser.com
Tools to monitor RxSight Inc. recovery probabilityWeekly Risk Report & Target Return Focused Picks - newser.com
OC500 2025: SHELLEY THUNEN - Orange County Business Journal
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against RxSight, Inc. (RXST) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Best data tools to analyze RxSight Inc. stock2025 Retail Activity & Technical Buy Zone Confirmations - newser.com
Is RxSight Inc. meeting your algorithmic filter criteriaMarket Trend Summary & Smart Allocation Stock Tips - newser.com
Is RxSight Inc. stock a top momentum play2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Applying Elliott Wave Theory to RxSight Inc.Market Sentiment Summary & AI Optimized Trading Strategy Guides - newser.com
Will RxSight Inc. stock benefit from commodity pricesForecast Cut & Long-Term Growth Plans - newser.com
Does RxSight Inc. qualify in momentum factor screeningQuarterly Performance Summary & High Yield Equity Trading Tips - newser.com
Looking at the Narrative for RxSight After Upgraded Guidance and Analyst Revisions - Yahoo Finance
Midday Stock Roundup: EnVVeno plunges 34% - Orange County Business Journal
Why RxSight Inc. stock is favored by pension fundsMarket Activity Report & Technical Confirmation Trade Alerts - newser.com
RxSight, Inc.'s (NASDAQ:RXST) Shares Climb 35% But Its Business Is Yet to Catch Up - 富途牛牛
RxSight, Inc. (RXST) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):